Concepedia

Christina Gamba‐Vitalo

CG

Statistics

Publications

18

Citations

3.5K

H-Index

16

Active since

1979

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Massachusetts Institute of Technology

New York University

Christina Gamba‐Vitalo is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, cell biology, and health sciences.

Top concepts

Publications per year

1979–2013

18

Publications

18

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

Teresa Coelho, David Adams, Ana Silva et al. · New England Journal of Medicine · 2013 · 947 citations · Full text

First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

Josep Tabernero, Geoffrey I. Shapiro, Patricia LoRusso et al. · Cancer Discovery · 2013 · 691 citations

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Maria Frank-Kamenetsky, Aldo Grefhorst, Norma N. Anderson et al. · Proceedings of the National Academy of Sciences · 2008 · 635 citations · Full text

Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver

Akin Akinc, Michael S. Goldberg, June Qin et al. · Molecular Therapy · 2009 · 347 citations · Full text

, , +9

A status report on RNAi therapeutics

Akshay Vaishnaw, Jared Gollob, Christina Gamba‐Vitalo et al. · Silence · 2010 · 294 citations · Full text

1–5 of 18